Renal Cancer - Results from #4920

The use of intraoperative cell salvage in urologic oncology October 2, 2017

Characterization of Patients With Poor-Risk Metastatic Renal-Cell Carcinoma: Results From a Pooled Clinical Trials Database. October 1, 2017

Expression of inflammatory lipopolysaccharide binding protein (LBP) predicts the progression of conventional renal cell carcinoma - a short report September 29, 2017

Immunotherapy: A New (and Old) Approach to Treatment of Soft Tissue and Bone Sarcomas September 29, 2017

RPS6KA4/MIR1237 and AURKC promoter regions are differentially methylated in Wilms' tumor September 29, 2017

Surgical resection of locally recurrent renal cell carcinoma after nephrectomy: Oncological outcome and predictors of survival September 29, 2017

Comparison of perioperative, renal and oncologic outcomes in robotic-assisted versus open partial nephrectomy September 29, 2017

Long non-coding RNA HOTAIR promotes cell migration by upregulating insulin growth factor-binding protein 2 in renal cell carcinoma September 28, 2017

Analysis of long non-coding RNA expression profiles in clear cell renal cell carcinoma September 28, 2017

Nivolumab and pembrolizumab: Monoclonal antibodies against programmed cell death-1 (PD-1) that are interchangeable September 28, 2017

Development of Bell's Palsy After Treatment With Ipilimumab and Nivolumab for Metastatic Melanoma: A Case Report September 28, 2017

Venous Thromboembolism Risk in Patients With Locoregional Urothelial Tract Tumors September 28, 2017

A five-long non-coding RNA signature to improve prognosis prediction of clear cell renal cell carcinoma September 27, 2017

Efficacy of percutaneous radiofrequency ablation may vary with clear cell renal cell cancer histologic subtype September 27, 2017

Intratumor heterogeneity of immune checkpoints in primary renal cell cancer: Focus on HLA-G/ILT2/ILT4 September 27, 2017

Differential expression of the sirtuin family in renal cell carcinoma: Aspects of carcinogenesis and prognostic significance September 27, 2017

High mucin 5AC expression predicts adverse postoperative recurrence and survival of patients with clear-cell renal cell carcinoma September 26, 2017

Outcome of papillary versus clear cell renal cell carcinoma varies significantly in non-metastatic disease September 26, 2017

Survival of metastatic renal cell carcinoma patients continues to improve over time, even in targeted therapy era September 26, 2017

Perioperative and Oncologic Outcomes of Nephrectomy and Caval Thrombectomy Using Extracorporeal Circulation and Deep Hypothermic Circulatory Arrest for Renal Cell Carcinoma Invading the Supradiaphragmatic Inferior Vena Cava and/or Right Atrium September 26, 2017

Page 247 of 456